5Neff B, Neri GC, Bandinelli M. Differences between eamitine deriva- tives and coenzyme Q10 in preventing in vitro doxorubiein-related cardiac damages[ J]. Oncology, 1988,45 ( 3 ) :242-246.
二级参考文献12
1DeVita VT, Hellman S, Rosenberg SA. Cancer : Principles and practice of oncology [M]. 7th Ed.Philadelphia : Lippincott Williams & Wilkins Publisher, 2005 : 385.
2Launchbury AP, Habboubi N. Epruibicin and doxorubicin : A comparison of their characteristics, therapeutic activity and toxicity [J]. Cancer Treat Rev, 1993, 19(3): 197-228.
3Mouridesn HT. New cytotoxic drugs in treatment of breast cancer[J]. Acta Oncol, 1990, 29(3) : 343-347.
4Grenier MA, Lipshultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults [ J ]. Semin Oncol, 1998, 25(10) : 72-85.
5Yeung TK, Chakrabarti K, Wilding D, et al. Modification of doxorubiein-induced cardiotoxicity : Manipulation of the dosage schedule [ J ]. Human & Experimental Toxicology, 2002, 21(11) : 607-614.
6van Dalen EC, van der Pal H J, Caron HN, et al. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy [J]. Cochrane Datebase Syst Rev, 2006, 4 : CD005008.
7von Hoff DD, Layard MW, Basa P, et a|. Risk factors for doxorubicin-induced congestive heart failure [ J ]. Ann Intern Med, 1979, 91(5) : 710-717.
8Gianni L, Herman EH, Steven E, et al. Anthracycline cardiotoxicity : From bench to bedside [ J ]. J Clin Oncol, 2008, 26(22) : 3777-3784.
9Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and higher dnlg dose as risk factors for late eardiotoxic effects of doxorubicin therapy for childhood cancer [ J ]. N Engl J Med, 1995, 332(26) : 1738-1743.
10Bangham AD, Home RW. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope [ J ]. J Molec Biol, 1964, 5(8) : 660-668.
3Rohrdanz E,Obertrifter B.Influence of Adriamycin and paraquat on antioxidant enzyme expression in primary rat hepatoeytes[J].Arch Toxieol,2000,74(425):231-237.
4Nasser MW,Datta J,Nuovo G,et al.Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis by miR-1[J].J Biol Chem,2008,283(48):394-405.
5Schimmel KJ,Richel DJ,Brink RB,et al.Cardiotoxicity of cytotoxic drugs[J].Cancer Treat Rev,2004,30(2):181-91.
